As the life sciences, medtech, and diagnostic industries continue to grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and investors navigate the many evolving and emerging...more
7/9/2025
/ Abbreviated New Drug Application (ANDA) ,
Artificial Intelligence ,
Budget Reconciliation ,
Deregulation ,
Drug Pricing ,
EU ,
Food and Drug Administration (FDA) ,
Healthcare Reform ,
Life Sciences ,
Medicaid ,
Medical Devices ,
Medical Technology Companies ,
Medicare ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Regulatory Reform ,
Regulatory Requirements ,
Tariffs ,
Trump Administration ,
UK
As Washington prepares for new leadership in January 2025, significant policy changes appear on the horizon. The incoming administration’s agenda suggests a substantial shift in US economic and regulatory priorities, with...more
1/7/2025
/ Artificial Intelligence ,
Blockchain ,
Corporate Governance ,
Corporate Taxes ,
Cybersecurity ,
Department of Labor (DOL) ,
Digital Assets ,
Environmental Social & Governance (ESG) ,
Equal Employment Opportunity Commission (EEOC) ,
Federal Contractors ,
Federal Labor Laws ,
Healthcare ,
Legislative Agendas ,
Life Sciences ,
Loper Bright Enterprises v Raimondo ,
NLRB ,
Privacy Laws ,
Public Procurement Policies ,
Regulatory Agenda ,
Tax Cuts and Jobs Act ,
Trade Relations ,
Trump Administration ,
US Trade Policies